Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

US drug prices are higher than anywhere else in the world. Congress has been trying to figure out who's to blame, but there has been a lot of finger pointing.

Senator Ron Wyden of Oregon is calling for Congress to take action."In case there was any doubt, Big Pharma is not about to start self-policing their pricing practices," he said on Monday., I'll be curious to see what actions Congress decides to adopt going forward to keep a lid on drug prices. Speaking of the intersection of health and tech, Emma reported on why Morgan Stanley thinks the healthcare industry should be taking Apple very seriously.

Emma also has a deep dive into what you need to know about all the funding flowing into clinical trial startups.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 729. in EG

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Clinical Trials Need Help From Technology To Speed New Drugs To MarketIf the biggest challenges pharma companies face relate to technology and digitization, the solutions need to come from technology companies. Oracle PLEASE do something abt the new male birth control pill. one small study complete-- public use ten years away?!? Texas is considering charging a woman who has an abortion with murder. she is only 50% responsible for the pregnancy! stopthesperm Oracle We all want solid products to be available ASAP. We also recognize desire for profits may lower some “professionals”product concerns. productsafety business health ConsumerReports
مصدر: Forbes - 🏆 394. / 53 اقرأ أكثر »